Zimbabwe has declined a major American health deal worth $367m (272 million pounds) spanning five years due to Washington's demand for confidential biological samples.
The decision was revealed following a official document dated December was leaked, revealing that President Emmerson Mnangagwa felt the deal was "lopsided".
An official spokesperson has since explained that the US was seeking genetic material for research and profit but was unwilling to share the benefits from any future treatments.
"We must now begin the difficult and regrettable process of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had donated over $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for more dialogue to secure a deal agreeable to both sides so the country's vital HIV treatment initiative can continue.
Broader Background
This rejection follows a similar situation in Kenya, where a court blocked a related deal with the US following legal challenges were raised about the security of citizens' health data.
Since resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump argued its expenditure was "wasteful" and his administration was seeking direct bilateral deals to enhance transparency and responsibility.
According to reports, 16 nations in Africa have so far agreed to similar health pacts, constituting over $18.3bn in new funding.
Details of the Declined Deal
This assistance for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment through American-funded initiatives," the Ambassador added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, with no corresponding assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.
"In essence, our nation would provide the basic resources for medical research without any certainty that the end products would be accessible to our people should a new pandemic arise."
National Interest and Global Health
Mangwana further pointed out that the American exit from the global health body and its push of one-on-one health agreements were disrupting structures previously set up through the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with potential global health emergencies.
"This mechanism is designed to guarantee that when a nation contributes its samples, the benefits – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We are open to ongoing discussions with our American counterparts on how future co-operation might be structured in a manner that honours the independence and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but recommended that negotiations need to persist considering much of the nation's HIV programmes were funded by international support.
"In cases where specific concerns exist, such as those involving information security or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," the group said.
This impasse underscores the ongoing tensions between accepting much-needed international aid and safeguarding a country's data in an ever more data-driven world.